INO Inovio Pharmaceuticals, Inc. Loading...

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
? ?
21:50
Aug 20
svtrivo Semiconductor Industry Commentator
Author reflects on past losses in INO and observes MRNA's volatility.
Author reflects on past losses in INO and observes MRNA's volatility, but makes no current forward-looking trade call.
INO
LOW
10:56
Aug 13
DeItaone Twitter news aggregator (Walter Bloomberg)
Wolfe Research, JPMorgan, Citizens, Citi, Jefferies, RBC, Wells Fargo, Cantor Fitzgerald.
Wolfe Research, JPMorgan, Citizens, Citi, Jefferies, RBC, Wells Fargo, Cantor Fitzgerald, Roth/MKM, UBS, BofA, and Nomura issue multiple analyst upgrades and downgrades with various price target changes across a broad set of stocks.
INO

About INO Analyst Coverage

Buzzberg tracks INO (Inovio Pharmaceuticals, Inc.) across 2 sources. 0 bullish vs 0 bearish calls from 2 analysts. Sentiment: evenly split. 2 total trade ideas tracked. Latest voices: svtrivo, DeItaone.